| Net loss | |
| Depreciation and amortization | |
| Non-controlling interest | |
| Discount amortization on notes payable | |
| Provision for doubtful accounts | |
| Loss from disposal of property | |
| Loss from extinguishment of debt | |
| Equity based expenses | |
| Accounts receivable | |
| Other current assets and other non-current assets | |
| Accounts payable and accrued liabilities | |
| Accrued claims payable | |
| Accrued pharmacy payable | |
| Income taxes payable | |
| Other liabilities | |
| Net cash provided by (used in) operating activities | 1.3M |
| Additions to property and equipment, net | 0 |
| Net cash used in investing activities | 0 |
| Net proceeds from the issuance of common stock | |
| Net proceeds from the issuance of note obligations | 0 |
| Long-term financing | |
| Redemption of note obligations | |
| Repayment of debt | -456K |
| Net cash provided by financing activities | -456K |
| Net increase (decrease) in cash and cash equivalents | 843K |
| Cash and cash equivalents at beginning of period | 920K |
| Cash and cash equivalents at end of period | 1.76M |
| Interest | 147K |
| Property acquired under capital leases | |
| Conversion of notes payable and accrued interest to common stock | |
| Common stock and warrants issued for outside services | 135K |
| Net gain credited to deficit from sale of subsidiary | |